I get being upset that MANF is under Healixa's roo
Post# of 30025
(Total Views: 381)
Posted On: 07/15/2021 2:14:02 AM
I get being upset that MANF is under Healixa's roof.
The deal was something AMBS really needed at the time. They were able to retain Eltoprazine which in the end could bring in cash far quicker.
I like what CURR is doing with CBD & the adhesive. EMOR has the possibility to do the same.
Dr. Lauren Chung could prove to be a great connection.
Elto will be the driving force behind AMBS once the new CEO is named in my opinion.
We still have Hempori, the ownership in Todos, Royalties from LymPro, Royalties from Healixa (if when they move forward with the assets) and the preferred shares in Healixa in April 22'.
I am going off filings. There could have been deals not mentioned or other things that haven't been announced.
We just have to wait and see.
The deal w/ Healixa (EMOR) "could" end up paying out far more far quicker than putting money into trying the same old thing, borrowing money and hoping to make deals JV's etc.
I'm all about getting the pps moving as fast as possible.
We're getting close to that I believe.
If it takes, 6 months or even into 22, I can wait.
As a Holding Company AMBS is now in position to begin collecting money when the assets start producing.
As for the CEO message from Ian, interesting.
I like and respect the group he put together. Solid team and backgrounds.
They are looking to do the right thing and not pacify Wall Street immediately and that's fine with me.
Build a solid company then introduce it to main street.
Looks like 2H of 21 could produce big results for them.
Personally I am all about making money here and if the pps moves a little that's all I need, but I expect it to do far more than that with little operational expenses, paying down debt, royalties, money from Elto, Hempori and selling shares in invested companies.
The deal was something AMBS really needed at the time. They were able to retain Eltoprazine which in the end could bring in cash far quicker.
I like what CURR is doing with CBD & the adhesive. EMOR has the possibility to do the same.
Dr. Lauren Chung could prove to be a great connection.
Elto will be the driving force behind AMBS once the new CEO is named in my opinion.
We still have Hempori, the ownership in Todos, Royalties from LymPro, Royalties from Healixa (if when they move forward with the assets) and the preferred shares in Healixa in April 22'.
I am going off filings. There could have been deals not mentioned or other things that haven't been announced.
We just have to wait and see.
The deal w/ Healixa (EMOR) "could" end up paying out far more far quicker than putting money into trying the same old thing, borrowing money and hoping to make deals JV's etc.
I'm all about getting the pps moving as fast as possible.
We're getting close to that I believe.
If it takes, 6 months or even into 22, I can wait.
As a Holding Company AMBS is now in position to begin collecting money when the assets start producing.
As for the CEO message from Ian, interesting.
I like and respect the group he put together. Solid team and backgrounds.
They are looking to do the right thing and not pacify Wall Street immediately and that's fine with me.
Build a solid company then introduce it to main street.
Looks like 2H of 21 could produce big results for them.
Personally I am all about making money here and if the pps moves a little that's all I need, but I expect it to do far more than that with little operational expenses, paying down debt, royalties, money from Elto, Hempori and selling shares in invested companies.
(1)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼